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absence of HID. Now this has been elegantly confirmedSignaling Survival:
by Bergmann et al. in a paper presented in this issue ofHow Axons Rescue Their Glia Developmental Cell.
The midline glia of the embryonic central nervous sys-
tem provide a powerful model to examine survival sig-
naling through the EGFR/RAS/MAPK pathway (ScholzThe trophic theory of cell survival hypothesizes that
et al., 1997; Bergmann et al., 2002). In the fully developedcell number is regulated by survival signals generated
embryo, these midline glia ensheath the commissuralby other cells. Work published in this issue of Develop-
axon tracts of the ventral ganglia. At stage 13 of develop-mental Cell confirms that neurons can provide trophic
ment, ten to twelve of these cells are found in eachsupport for glia in Drosophila, and fills in important
repeating segment of the ventral ganglia. By late em-molecular details of this interaction.
bryogenesis, all but three of these cells per segment
have undergone apoptosis (see Figure). The apoptosisPrevious studies in flies have demonstrated that activa-
of these cells is regulated by the hid, grim, and reapertion of the Drosophila EGF receptor (EGFR) by its ligand
genes (Zhou et al., 1995). These genes regulate all em-secreted SPITZ (sSPITZ) is sufficient to promote the
bryonic apoptosis, with each gene contributing to theinappropriate survival of cells in the developing eye and
death of subpopulations of cells. In the midline glia,in the embryo (reviewed in Kurada and White, 1999). In
reaper and grim appear to regulate the death of approxi-addition, inhibition of the EGFR or of the downstream
mately half of the cells, and hid is required for the deathRAS/MAPK signaling pathway induces widespread apo-
of the other half (Zhou et al., 1997). Consequently, inptosis. The proapoptotic gene hid has been implicated
hid mutants, six midline glia survive in each segment.in this apoptosis. EGFR/RAS/MAPK signaling negatively
Hyperactivation of the EGFR/RAS/MAPK pathway alsoregulates the activation of HID both directly and indi-
permits the survival of six midline glia, while inhibitionrectly. The levels of hid mRNA are increased when
of the pathway results in the death of all of the midlineEGFR/RAS/MAPK signaling is decreased, and MAPK
glia (Scholz et al., 1997; Stemerdink and Jacobs, 1997;also appears to inactivate HID directly by phosphoryla-
Bergmann et al., 2002). Based on the previous work intion (Bergmann et al., 1998; Kurada and White, 1998).
the eye, it was predicted that six midline glia wouldIn the absence of HID, apoptosis induced by decreased
survive in the absence of EGFR signaling if HID wasMAPK signaling in the eye is reduced (Kurada and White,
inactive. Bergmann et al. tested this directly, and found1998). These data strongly suggest that EGFR/RAS/
it to be true. In addition, they found that the six cellsMAPK signaling is required to suppress HID activity,
that survive when HID is eliminated are the same six cellspreventing apoptosis, and that cells have a lower re-
quirement for EGFR/RAS/MAPK survival activity in the that survive when EGFR signaling is hyperactivated. This
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Survival Signaling in the Midline during Dro-
sophila Development
In wild-type animals, approximately ten to
twelve midline glia (yellow) are present at
stage 13 of development. Those cells in close
contact with the axons (green) are exposed
to secreted SPITZ (sSPITZ), a ligand for the
EGF receptor (EGFR). EGFR, signaling
through the MAPK pathway, inactivates the
activity of the proapoptotic gene hid. In this
way, three cells receiving a high level of EGFR
ligand are prevented from undergoing apo-
ptosis. These surviving glia are responsible
for separating and ensheathing the commis-
sural axon tracts. In the absence of EGFR all
of the midline glia undergo apoptosis, and
the commissural tracts are fused. If hid is
mutated, six of the midline glia survive, even
in the absence of EGFR signaling. This phe-
notype can be reproduced by hyperactivating
the EGFR signal through activating mutations
in MAPK or by supplying an excess of the
sSPITZ ligand.
suggests that these six cells are somehow predeter- Another question raised by this work is whether EGFR
signaling has additional roles in the midline glia. Do themined to be EGFR dependent, while the remaining cells
die independent of the EGFR signal. One possibility is cells that survive when both EGFR and HID are absent
function like wild-type midline glia? Intriguingly, theythat HID is only expressed in these six cells, and thus
only these cells depend on EGFR to suppress HID activ- may not. Work from Roger Jacobs shows that when all
cell death is prevented in spitz mutants, the commissurality. Alternatively, reaper and grim expression in the other
cells may be sufficient to induce death even when HID axon tracts are not properly ensheathed (Dong and Ja-
cobs, 1997). This suggests that midline glia receive bothactivity is suppressed by EGFR signaling.
A major contribution of this paper is the demonstration survival signals and signals for proper differentiation
through the EGFR signal transduction pathway.that the EGFR ligand sSPITZ is generated in the nervous
system. Thus, the axons provide the survival factor for Finally, it is interesting to speculate on the develop-
mental justification for these exquisite controls on celltheir ensheathing glia. Available sSPITZ must be insuffi-
cient to support the survival of all six EGFR-dependent number. Why not simply start with three midline glia? It
seems likely that trophic survival signaling allows forcells in the wild-type animal. sSPITZ availability may be
restricted by limited processing of the inactive precur- more flexibility during development. If one glia is mis-
placed during development, another can take over itssor, a low level of sSPITZ relative to Argos, a secreted
inhibitory ligand for EGFR, or spatial limitations on function. Notably, hid mutants, which contain extra cells
both at the midline and elsewhere, are viable to adultsSPITZ availability. The data suggest that all of these
limitations may play a role. Bergmann et al. show that stages, albeit very short lived. Thus, HID-dependent
elimination of cells that do not receive proper survivalsSPITZ is only produced in the axons. Mutations in the
genes rhomboid and star, both required for sSPITZ pro- signals may increase the robustness of the animal.
cessing, result in midline glia death, while overexpres-
sion of these genes in the neurons results in increased
Kristin Whitemidline glia survival, indicating that sSPITZ processing
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Harvard Medical Schoolmidline glia. If the formation of the commissural axon
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13th Streetthis death is prevented in the absence of HID (Bergmann
Charlestown, Massachusetts 02129et al., 2002). WRAPPER, an Ig superfamily protein pres-
ent on the surface of the midline glia, may be required
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for the formation of proper midline glia-axon contacts,
as in the absence of WRAPPER, all of the midline glia Bergmann, A., Agapite, J., McCall, K., and Steller, H. (1998). Cell 95,
die (Noordermeer et al., 1998). It would be interesting 331–341.
to test whether WRAPPER function is required for cells Bergmann, A., Tugentman, M., Shilo, B.-Z., and Steller, H. (2002).
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for nuclear transport receptor binding, a cyclophilin ho-A New Clue at the Nuclear Pore:
mology region, and other potentially functional domainsRanBP2 Is an E3 Enzyme for SUMO1 (Yokoyama et al., 1995; see Figure, panel A). A region
of this protein that was originally termed the IR domain
(Yokoyama et al., 1995) is the site of RanGAP1 binding
(Matunis et al., 1998) and also associates strongly withA recent paper in Cell shows that the large nucleoporin
the E2 enzyme for SUMO1, Ubc9 (Saitoh et al., 1998).RanBP2 can act as an E3 enzyme for the ubiquitin-
This region of RanBP2 can be modified by conjugationlike protein SUMO1. These intriguing results raise im-
to SUMO1 (Saitoh et al., 1998).portant questions about the mechanism of SUMO1
Pichler et al. (2002) found that the IR domain not onlyconjugation, the relationship of SUMO1 to nuclear
became modified in in vitro assays containing SUMO1transport, and the regulation of RanBP2 in the pore.
and E1 and E2 enzymes, but that it catalyzed its own
hypermodification and the modification of a genuineSUMO1 is a small ubiquitin-like protein. In 1996, it was
SUMO1 substrate, Sp100. In these reactions, RanBP2shown that SUMO1 becomes covalently linked to Ran-
showed considerable substrate specificity: a mutationGAP1, the GTPase-activating protein for the RanGTPase
in the physiological attachment residue drastically de-(reviewed in Melchior, 2000). Ran is required for nuclear
creased modification of Sp100, and RanBP2 did nottransport, cell cycle control, mitotic spindle formation,
substantially modify another SUMO1 conjugation target,and postmitotic nuclear assembly. Compartmentaliza-
p53. Two aspects of these findings were particularlytion of Ran’s regulators between the nucleus and cytosol
surprising: first, RanBP2 did not appear to affect theleads to an asymmetry in its nucleotide binding states
conjugation of RanGAP1, even though these proteinsbetween these compartments during interphase and
are typically found in a very tight complex under mostpromotes the directionality of nuclear transport by di-
circumstances. Second, the hypermodification ofrecting the loading and unloading of transport receptors
RanBP2 included the formation of SUMO1 chains. Thisin a manner that is appropriate to each cellular location
was unexpected because SUMO1 has not been pre-(Gorlich and Kutay, 1999). Modification of RanGAP1 by
viously found to polymerize into chains in vivo.SUMO1 promotes its association to RanBP2 (Melchior,
Pichler et al. (2002) demonstrated that free Ubc9 en-2000), a 358 kDa Ran binding protein on the cytosolic
hances the capacity of a RanBP2-Ubc9 complex to cata-face of the nuclear pore (Yokoyama et al., 1995; see
lyze conjugation of Sp100. These results would be con-Figure, panel A).
sistent with the notion that RanBP2 interacts with Ubc9Subsequent investigations revealed that RanGAP1
in a transient fashion, undergoing multiple rounds ofand other proteins become covalently linked to SUMO1
association and dissociation, perhaps coupled to eachin a manner very similar to ubiquitin conjugation (Mel-
conjugation event. Numerous additional questions re-chior, 2000). The SUMO1 pathway utilizes activation (E1)
main regarding the mechanism whereby RanBP2 actsand conjugation (E2) enzymes that show similarity in
as an E3 enzyme. For instance, the IR region of RanBP2both sequence and biochemical mechanism to analo-
does not possess RING finger motifs found in othergous enzymes in the ubiquitin pathway. A flurry of new
SUMO1 E3 enzymes (Hochstrasser, 2001; Yokoyama etreports has demonstrated the existence of SUMO1 li-
al., 1995), nor is it inactivated by treatment with alkylat-gases (E3 enzymes), including the PIAS family of RING
ing agents (Pichler et al., 2002). These facts suggestfinger proteins (reviewed in Hochstrasser, 2001). The
that the biochemical mechanism of RanBP2’s activitysearch for E3 enzymes has now provided a surprising
as an E3 enzyme is likely to be novel, and its investiga-new twist in the tale of SUMO1 at the nuclear pore: in
tion will be of considerable future interest.the January 11th issue of Cell, Pichler et al. show that
What might be the significance of RanBP2’s functionRanBP2 is an E3 enzyme for SUMO1.
as a SUMO1 ligase, and how might this activity be re-When carrying out in vitro assays to examine the up-
lated to the other functions of this large protein? Onetake of tagged SUMO1 into nuclei, Pichler et al. (2002)
intriguing possibility is that RanBP2 couples nuclearnoticed that it accumulated on the cytosolic face of the
translocation with conjugation for a subset of SUMO1nuclear pore. They went on to find that tagged SUMO1
targets (Pichler et al., 2002; see Figure, panel B). It isbecame conjugated to proteins that were at the pore
attractive to speculate that the interaction of import re-under these circumstances. Intrigued by this result, Pil-
ceptors with RanBP2 during the process of protein im-cher et al. investigated the role of RanBP2 in this phe-
port may promote the conjugation of their cargo andnomenon. The RanBP2 protein encodes domains that
can bind to RanGTP and RanGDP, as well as repeats thereby contribute to the specificity of conjugation.
